APA (7th ed.) Citation

M, S., M, V., R, H., S, T., S, B., S, P., . . . A, H. (2016). Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting. Oncoimmunology, 5(5), e1136046. https://doi.org/10.1080/2162402X.2015.1136046

Chicago Style (17th ed.) Citation

M, Siurala, Vähä-Koskela M, Havunen R, Tähtinen S, Bramante S, Parviainen S, Mathis JM, Kanerva A, and Hemminki A. "Syngeneic Syrian Hamster Tumors Feature Tumor-infiltrating Lymphocytes Allowing Adoptive Cell Therapy Enhanced by Oncolytic Adenovirus in a Replication Permissive Setting." Oncoimmunology 5, no. 5 (2016): e1136046. https://doi.org/10.1080/2162402X.2015.1136046.

MLA (9th ed.) Citation

M, Siurala, et al. "Syngeneic Syrian Hamster Tumors Feature Tumor-infiltrating Lymphocytes Allowing Adoptive Cell Therapy Enhanced by Oncolytic Adenovirus in a Replication Permissive Setting." Oncoimmunology, vol. 5, no. 5, 2016, p. e1136046, https://doi.org/10.1080/2162402X.2015.1136046.